---
title: "Swiss Market Comes Off Early Lows, Settles 0.73% Down"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278430014.md"
description: "Swiss stocks experienced a slight recovery after an early decline, closing 0.73% down amid global market trends. The SMI index fell to 12,685.18 before settling at 13,000.09, losing 95.46 points. Major companies like Richemont and Roche saw declines, while Novartis and Logitech gained. Consumer confidence in Switzerland remained steady at -30 in February, with slight improvements in economic outlook compared to last year."
datetime: "2026-03-09T17:45:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278430014.md)
  - [en](https://longbridge.com/en/news/278430014.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278430014.md)
---

# Swiss Market Comes Off Early Lows, Settles 0.73% Down

(RTTNews) - After a sharp decline in early trades, Swiss stocks recovered a bit Monday morning, and then kept paring losses as the day progressed, but still ended the session on a negative note, in line with markets across the globe.

Deepening tensions in the Gulf following reports of explosions at Al Udeid Air Base, the largest United States military installation in the Middle East rendered the mood bearish.

The Swiss benchmark SMI, which tumbled to 12,685.18, losing more than 400 points, recovered to settle at 13,000.09, but still recorded a loss of 95.46 points or 0.73%.

Richemont ended down 3.25%. Roche Holding, Amrize, Sika and Julius Baer closed lower by 2.2%-2.6%.

Schindler Ps, Kuehne + Nagel, Holcim, ABB, SGS, Straumann Holding and Lonza Group lost 1%-2%. Geberit, Partners Group, Givaudan, UBS Group and Helvetia Baloise Holding also ended notably lower.

Novartis climbed about 1.7%. Logitech International moved up 1.63% and Swisscom advanced nearly 1%. Sandoz Group, Swiss Re and Swiss Life Holding also closed on positive note.

In economic news, Swiss consumer confidence held steady and negative in February, monthly survey results from the State Secretariat for Economic Affairs, or SECO, showed.

The consumer sentiment index stood at -30 in February, the same as in the previous month. The expected score was -29.

Nonetheless, the index improved from the previous year's reading of -34.0.

The economic outlook index improved to -31.0 from -37.0 from last year and from -34.0 in January. The sub-indexes for past financial situation and timing of major purchases strengthened from the past year's level, while the indicator for expected financial situation was broadly unchanged.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

### Related Stocks

- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [RITN.DE](https://longbridge.com/en/quote/RITN.DE.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)

## Related News & Research

- [FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment | RHHBY Stock News](https://longbridge.com/en/news/286594661.md)
- [Roche, Medicines Patent Pool sign deal to expand access to influenza drug](https://longbridge.com/en/news/286796802.md)
- [Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217) | RHHBY Stock News](https://longbridge.com/en/news/286036724.md)
- [Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD  | RHHBY Stock News](https://longbridge.com/en/news/283530415.md)
- [Saint Laurent CEO admits brand must do more to retain luxury shoppers](https://longbridge.com/en/news/286832185.md)